EUVIMEDEUVIMED entdecken
Crossref

The sodium-glucose cotransporter 2 inhibitor empagliflozin reverses hyperglycemia-triggered vascular endothelial cell dysfunction by regulating mitochondria dynamics

Qian Cheng, Rui Du iD, Jing Liu, Ping Qiu, Yonghe Hu

Endokrynologia Polska · 30.06.2026 · 77 (3) · 245-255

DOI: 10.5603/ep.110841 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endokrynologia Polska, online erschienen am 30.06.2026. Verfasst von Qian Cheng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesia, Huzhou Maternity & Child Health Care Hospital, Huzhou, China. Hauptthemen laut MEDLINE: Benzhydryl Compounds, Glucosides, Sodium-Glucose Transporter 2 Inhibitors, Mitochondrial Dynamics.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Benzhydryl CompoundsGlucosidesSodium-Glucose Transporter 2 InhibitorsMitochondrial DynamicsSodium-Glucose Transporter 2HyperglycemiaEndothelial CellsAnimalsMaleHumansMiceDiabetes Mellitus, ExperimentalHuman Umbilical Vein Endothelial CellsKruppel-Like Factor 4Mice, Inbred C57BL

Stichwörter der Autor:innen

AMPKKLF4SGLT2empagliflozinmitochondria dynamics

Substanzen

Benzhydryl CompoundsempagliflozinGlucosidesSodium-Glucose Transporter 2 InhibitorsSodium-Glucose Transporter 2Kruppel-Like Factor 4Slc5a2 protein, mouse

Autor:innen und Institutionen

  • Department of Anesthesia, Huzhou Maternity & Child Health Care Hospital, Huzhou, China.
  • Department of Anesthesia, Huzhou Maternity & Child Health Care Hospital, Huzhou, China. dandan20172024@163.com.
  • Department of Anesthesia, Huzhou Central Hospital, Affiliated Huzhou Hospital, Zhejiang University School of Medicine, Affiliated Central Hospital of Huzhou University, Huzhou, China.

ORCID-Profile: Rui Du

Zitieren

APA

Cheng, Q., Du, R., Liu, J., Qiu, P., & Hu, Y. (2026). The sodium-glucose cotransporter 2 inhibitor empagliflozin reverses hyperglycemia-triggered vascular endothelial cell dysfunction by regulating mitochondria dynamics. Endokrynologia Polska, 77(3), 245-255. https://doi.org/10.5603/ep.110841

Vancouver

Cheng Q, Du R, Liu J, Qiu P, Hu Y. The sodium-glucose cotransporter 2 inhibitor empagliflozin reverses hyperglycemia-triggered vascular endothelial cell dysfunction by regulating mitochondria dynamics. Endokrynologia Polska. 2026;77(3):245-255. doi:10.5603/ep.110841

BibTeX
@article{Cheng2026,
  author = {Cheng, Qian and Du, Rui and Liu, Jing and Qiu, Ping and Hu, Yonghe},
  title = {The sodium-glucose cotransporter 2 inhibitor empagliflozin reverses hyperglycemia-triggered vascular endothelial cell dysfunction by regulating mitochondria dynamics},
  journal = {Endokrynologia Polska},
  year = {2026},
  volume = {77},
  number = {3},
  pages = {245--255},
  doi = {10.5603/ep.110841}
}
Kostenlos starten →